Bioeq IP AG’s Lucentis Biosimilar Out-Licensing To Coherus BioSciences, Inc.

Paolo Bossi

Freshfields Bruckhaus Deringer LLP has advised Bioeq IP AG on its license and development agreement with Coherus BioSciences, Inc. The agreement enables Coherus to exclusively market…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now